Sharan Campleman
- Toxicology top 1%
- Forensic Toxicology and Drug Analysis 9
-
- Air Quality and Health Impacts 3
- Virology top 5%
- Rabies epidemiology and control 7
- Emergency Medicine top 5%
- Poisoning and overdose treatments 18
- Cancer Research top 10%
-
- Opioid Use Disorder Treatment 14
-
- Venomous Animal Envenomation and Studies 8
-
- Anesthesia and Sedative Agents 5
-
- Childhood Cancer Survivors' Quality of Life 3
- Co-authors
- Michael LipsettPaul M. WaxJeffrey BrentArti Parikh‐PatelJanet H. BatesRobin Taylor WilsonLee E. MooreAri S. Lewis
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Sharan Campleman
48 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 129
- Toxicology 172
- Health, Toxicology and Mutagenesis 358
- Virology 108
- Emergency Medicine 180
- Cancer Research 234
Countries citing papers authored by Sharan Campleman
This map shows the geographic impact of Sharan Campleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharan Campleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharan Campleman more than expected).
Fields of papers citing papers by Sharan Campleman
This network shows the impact of papers produced by Sharan Campleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharan Campleman. The network helps show where Sharan Campleman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sharan Campleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 3 | |
| 9 | Rapid development of the FDA ACMT COVID-19 ToxIC (FACT) pharmacovigilance pilot project to monitor adverse events reported in association with COVID-19 therapeutics | 2021 | 1 |
| 10 | 2020 | 1 | |
| 11 | 2019 | 15 | |
| 12 | 2018 | 16 | |
| 13 | 2017 | 34 | |
| 14 | 2017 | 85 | |
| 15 | 2016 | 73 | |
| 16 | 2015 | 12 | |
| 17 | 2014 | 7 | |
| 18 | 2014 | 103 | |
| 19 | 2013 | 18 | |
| 20 | 2006 | 102 |
About Sharan Campleman
Sharan Campleman is a scholar working on Toxicology, Emergency Medicine and Virology, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Poisoning and overdose treatments (18 papers), Opioid Use Disorder Treatment (14 papers), Forensic Toxicology and Drug Analysis (9 papers), Venomous Animal Envenomation and Studies (8 papers), Rabies epidemiology and control (7 papers), Anesthesia and Sedative Agents (5 papers), Air Quality and Health Impacts (3 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). The work is most often cited by research in Toxicology (172 citations), Health, Toxicology and Mutagenesis (358 citations) and Virology (108 citations). Sharan Campleman has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Michael Lipsett, Paul M. Wax, Jeffrey Brent, Arti Parikh‐Patel, Janet H. Bates, Robin Taylor Wilson, Lee E. Moore, Ari S. Lewis, Chad M. Thompson and Mina Suh. Their work appears in journals such as Journal of Medical Toxicology, Clinical Toxicology, Cancer, MMWR Morbidity and Mortality Weekly Report and International Journal of Environmental Research and Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.